What is he best known for?
The fields of study he is best known for:
Philip A. Barker mostly deals with Cell biology, Low-affinity nerve growth factor receptor, Neuroscience, Receptor and Programmed cell death.
His study in Cell biology is interdisciplinary in nature, drawing from both Inhibitor of apoptosis, Cancer research and Ubiquitin.
He interconnects Tropomyosin receptor kinase A and Trk receptor in the investigation of issues within Low-affinity nerve growth factor receptor.
His study looks at the relationship between Trk receptor and topics such as Tropomyosin receptor kinase B, which overlap with Brain-derived neurotrophic factor.
His Neuroscience study combines topics in areas such as Tumor necrosis factor alpha, Genetically modified mouse and Signal transduction.
His Programmed cell death research integrates issues from Cell survival and Growth inhibition.
His most cited work include:
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination (831 citations)
- Neurotrophin signaling through the p75 neurotrophin receptor. (582 citations)
- Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells. (365 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cell biology, Neuroscience, Low-affinity nerve growth factor receptor, Oceanography and Diatom.
The concepts of his Cell biology study are interwoven with issues in Apoptosis, Cancer research and Neurotrophic factors.
The Low-affinity nerve growth factor receptor study which covers Tropomyosin receptor kinase A that intersects with Receptor tyrosine kinase and Endocrinology.
His Oceanography study combines topics from a wide range of disciplines, such as δ18O and Quaternary.
His Diatom research includes elements of Environmental chemistry, Tropics, Sediment and Isotopes of oxygen.
As a part of the same scientific study, Philip A. Barker usually deals with the Nerve growth factor, concentrating on Molecular biology and frequently concerns with Gene.
He most often published in these fields:
- Cell biology (30.84%)
- Neuroscience (17.62%)
- Low-affinity nerve growth factor receptor (15.86%)
What were the highlights of his more recent work (between 2013-2021)?
- Neuroscience (17.62%)
- Cell biology (30.84%)
- Diatom (14.98%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Neuroscience, Cell biology, Diatom, Oceanography and Synapse.
His Neuroscience research is multidisciplinary, incorporating perspectives in Synaptic plasticity, Neurotrophin and Nerve growth factor.
In the subject of general Neurotrophin, his work in Tropomyosin receptor kinase A is often linked to Calpain, thereby combining diverse domains of study.
The Cell biology study combines topics in areas such as Apoptosis and Endocytosis.
His Diatom research incorporates elements of Trophic level, Sediment and Ecosystem, Carbon cycle.
Philip A. Barker works in the field of Receptor, focusing on Low-affinity nerve growth factor receptor in particular.
Between 2013 and 2021, his most popular works were:
- High Salt Intake Increases Blood Pressure via BDNF-Mediated Downregulation of KCC2 and Impaired Baroreflex Inhibition of Vasopressin Neurons (81 citations)
- Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation (63 citations)
- S100B protein activates a RAGE‐dependent autocrine loop in astrocytes: implications for its role in the propagation of reactive gliosis (51 citations)
In his most recent research, the most cited papers focused on:
Philip A. Barker focuses on Neuroscience, Neurotrophin, Cell biology, Tropomyosin receptor kinase B and Brain-derived neurotrophic factor.
His Neuroscience study incorporates themes from Glutamate receptor, Apoptosis and Metaplasticity.
As a part of the same scientific family, Philip A. Barker mostly works in the field of Neurotrophin, focusing on Neurotrophin-3 and, on occasion, Low-affinity nerve growth factor receptor, Trk receptor and Tropomyosin receptor kinase A.
His study brings together the fields of Cancer research and Low-affinity nerve growth factor receptor.
His work carried out in the field of Cell biology brings together such families of science as Neuroplasticity, Microglia and Cytoskeleton.
His Tropomyosin receptor kinase B study integrates concerns from other disciplines, such as Endocrinology and Epilepsy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
